Overview |
bsm-54504R |
Phospho-JAK2(Y1007+Y1008) Monoclonal Antibody |
WB, IHC-P, IF(ICC), IP, IHC |
Human, Mouse, Rat |
Specifications |
Unconjugated |
Rabbit |
Synthetic phospho-Peptide corresponding to residues surrounding Tyr1007 and 1008 of human JAK2. |
Tyr1007+Tyr1008 |
Monoclonal |
3G6 |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 1xTBS (pH7.4), 1%BSA, 40%Glycerol and 0.05% Sodium Azide. |
Store at -20°C for 12 months. |
Target |
3717 |
O60674 |
Cytoplasm, Nucleus, Endomembrane system |
JAK 2 antibody, JAK-2 antibody, JAK2 antibody, JAK2_HUMAN antibody, Janus Activating Kinase 2 antibody, Janus kinase 2 (a protein tyrosine kinase) antibody, Janus kinase 2 antibody, JTK 10 antibody, JTK10 antibody, kinase Jak2 antibody, OTTHUMP00000043260 antibody, THCYT3 antibody, Tyrosine protein kinase JAK2 antibody, Tyrosine-protein kinase JAK2 antibody |
This gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis. [provided by RefSeq, Jul 2008] |
Application Dilution |
WB |
1:300-5000 |
IHC-P |
1:200-400 |
IF(ICC) |
1:50-200 |
IP |
1-2ug |
IHC |
|